Skip to content

Study on Electrophysiological Mechanism and Intervention Effectiveness of Insomnia Based on Abdominal Acupuncture and tACS Regulation Technology

Study on Electrophysiological Mechanism and Intervention Effectiveness of Insomnia Based on Abdominal Acupuncture and tACS Regulation Technology

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100042343
Enrollment
Unknown
Registered
2021-01-19
Start date
2021-02-01
Completion date
Unknown
Last updated
2021-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insomnia and drug-dependent insomnia

Interventions

Sponsors

Department of Health management, Aerospace Center Hospital, Peking University Aerospace School of Clinical Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Healthy control group Aged 18-65 years; No history of sleep disorder; PSQI= 7; (4) There are no serious organic diseases such as cardiovascular diseases, hepatic and renal insufficiency and mental illness. (5) Those aged 18-65 who are willing to accept this treatment and insist on treatment; (6) Volunteer to participate and sign informed consent. (7) Hamilton Anxiety Scale (HAMA) score = 6 months, and use your right hand; (2) The patient is conscious, without aphasia and intelligence disorder, and can understand the contents of the scale and cooperate with the treatment; (3) The total score of Pittsburgh Sleep Quality Index (PSQI) is >= 7; (4) There are no serious organic diseases such as cardiovascular diseases, hepatic and renal insufficiency and mental illness. (5) Those aged 40-65 who are willing to accept this treatment and insist on treatment; (6) Volunteer to participate and sign informed consent. (7) The total score of Hamilton Anxiety Scale (HAMA) is 7-21; (8) The total score of Hamilton Depression Scale (HAMD) is > 7 and <= 17.

Exclusion criteria

Exclusion criteria: Patients with primary insomnia (1) do not meet the above conditions; ? Those who use other drugs to treat insomnia; ? Insomnia caused by drugs, emergency events, environmental and psychological factors and bad habits; ? Insomnia caused by severe neurasthenia, stress disorder, personality disorder, organic diseases and psychoactive substances; ? The living environment (objectively) will change greatly during the observation period; ? Severe liver and kidney insufficiency, or serious diseases of various systems; ? Those who cannot insist on treatment due to long distance or other reasons; 8 pregnant women, lactating women and other special groups; Those who meet any of the above items are not allowed to join the group. Group of EDIAD patients (1) do not meet the above conditions; ? Those who use drugs other than estazolam to treat insomnia; ? Insomnia caused by drugs, emergency events, environmental and psychological factors and bad habits; ? Insomnia caused by severe neurasthenia, stress disorder, personality disorder, organic diseases and psychoactive substances; ? According to the researcher's judgment, there are other situations that have the possibility of low enrollment or complicate enrollment, such as frequent changes in the working environment and frequent business trips; 6 pregnant women, lactating women, high fever, coagulation dysfunction; ? Severe hepatic and renal insufficiency, or complicated with serious diseases of various systems; ? Alcoholism or other material dependence; Pet-name ruby due to distance or other reasons can't insist on treatment; Attending external use of alcohol allergy or allergic to acupuncture needles; Abdominal organ diseases or abdominal scars affect those who apply needles in the abdomen; Patients who adopt other treatment schemes or participate in other clinical studies; Those who meet any of the above items are not allowed to join the group.

Design outcomes

Primary

MeasureTime frame
Dosage of estazolam;Drug reduction rate of estazolam;Pittsburgh Sleep Quality Index;

Secondary

MeasureTime frame
Benzodiazepine Withdrawal Symptom Questionnaire;Hamilton Anxiety Scale;Hamilton Depression Scale;EEG;

Countries

China

Contacts

Public ContactWang Jing

Department of Health Management, Aerospace Center Hospital, Peking University Aerospace School of Clinical Medicine

happyksg@126.com+86 15910525655

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026